Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
235
-
Total 13F shares, excl. options
-
101,146,307
-
Shares change
-
+4,373,773
-
Total reported value, excl. options
-
$3,918,572,903
-
Value change
-
+$154,288,770
-
Put/Call ratio
-
59%
-
Number of buys
-
125
-
Number of sells
-
102
-
Price
-
$38.77
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2022
As of 31 Mar 2022 FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) had 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 101,146,307 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, Bellevue Group AG, STATE STREET CORP, Casdin Capital, LLC, and JOHNSON & JOHNSON.
This table shows 235 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.